-
Founded in:
1985-08-12 -
Country:
China -
Address:
No. 888, Antai 5th Road, Chengdu Hi-tech Zone -
Tax NO.:
91510100202368620M -
Registered Funds:
320 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Human Hepatitis B immunoglobulin BRP |
This product contains high titer hepatitis B surface antibodies, which can specifically bind to the corresponding antigen to play a role in passive immunity
More
This product contains high titer hepatitis B surface antibodies, which can specifically bind to the corresponding antigen to play a role in passive immunity |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| human immunoglobulin |
Stimulate the body to produce anti-histamine antibodies, thereby eliminating the pathogenic effects of endogenous histamine
More
Stimulate the body to produce anti-histamine antibodies, thereby eliminating the pathogenic effects of endogenous histamine |
0 | ||
| Histamine phosphate |
Stimulate the body to produce anti-histamine antibodies, thereby eliminating the pathogenic effects of endogenous histamine
More
Stimulate the body to produce anti-histamine antibodies, thereby eliminating the pathogenic effects of endogenous histamine |
51-74-1 | 0 | |
| Histamine dihydrochloride |
Stimulate the body to produce anti-histamine antibodies, thereby eliminating the pathogenic effects of endogenous histamine
More
Stimulate the body to produce anti-histamine antibodies, thereby eliminating the pathogenic effects of endogenous histamine |
56-92-8 | 6 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| human immunoglobulin |
Immunoglobulin injection is a passive immunotherapy. It is to transfer a large amount of antibodies contained in immunoglobulin to the recipient, so that the recipient can quickly reach a temporary immune protection state from a low or no immune state. Because antibodies and antigens interact with each other to directly neutralize toxins and kill bacteria and viruses. Therefore, immunoglobulin products have a certain effect on preventing bacterial and viral infections.
More
Immunoglobulin injection is a passive immunotherapy. It is to transfer a large amount of antibodies contained in immunoglobulin to the recipient, so that the recipient can quickly reach a temporary immune protection state from a low or no immune state. Because antibodies and antigens interact with each other to directly neutralize toxins and kill bacteria and viruses. Therefore, immunoglobulin products have a certain effect on preventing bacterial and viral infections. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| IMMUNOGLOBULIN G FROM MOUSE SERUM* |
This product contains broad-spectrum IgG antibodies against viruses, bacteria or other pathogens. In addition, the unique type of immunoglobulin and the unique type antibody form a complex immune network, so it has the dual therapeutic effects of immune replacement and immune regulation. After intravenous infusion, it can quickly increase the IgG level in the recipient's blood and enhance the body's anti-infection ability and immune regulation function.
More
This product contains broad-spectrum IgG antibodies against viruses, bacteria or other pathogens. In addition, the unique type of immunoglobulin and the unique type antibody form a complex immune network, so it has the dual therapeutic effects of immune replacement and immune regulation. After intravenous infusion, it can quickly increase the IgG level in the recipient's blood and enhance the body's anti-infection ability and immune regulation function. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Hepatitis B immune globulin |
Contains high titer anti-HBs, which can specifically bind to HBsAg and play a role in passive immunity. It may protect liver cells from infection by blocking HBV receptors, or neutralize viral particles in the circulating blood in the form of immune complexes, triggering antibody-dependent leukocyte-mediated toxic reactions and then killing target cells and causing lysis.
More
Contains high titer anti-HBs, which can specifically bind to HBsAg and play a role in passive immunity. It may protect liver cells from infection by blocking HBV receptors, or neutralize viral particles in the circulating blood in the form of immune complexes, triggering antibody-dependent leukocyte-mediated toxic reactions and then killing target cells and causing lysis. |
0 | ||
| Maltose |
Pharmacological action: This product contains high titer anti-HBs, which can specifically bind to HBsAg and play a role in passive immunity. Its mechanism of action is not very clear. It may protect liver cells from infection by blocking HBV receptors, or it may neutralize viral particles in the circulating blood in the form of immune complexes, triggering antibody-dependent leukocyte-mediated toxic reactions and then killing target cells and causing lysis. Toxicological studies: The results of preclinical animal tests of this product are as follows: 1. The results of general pharmacology studies showed that the use of 800, 1600, and 3200 IU/kg dosing groups and a single intravenous administration had no significant effect on the general mental state, behavioral activities, central nervous system and digestive system of mice; the use of 350,
More
Pharmacological action: This product contains high titer anti-HBs, which can specifically bind to HBsAg and play a role in passive immunity. Its mechanism of action is not very clear. It may protect liver cells from infection by blocking HBV receptors, or it may neutralize viral particles in the circulating blood in the form of immune complexes, triggering antibody-dependent leukocyte-mediated toxic reactions and then killing target cells and causing lysis. Toxicological studies: The results of preclinical animal tests of this product are as follows: 1. The results of general pharmacology studies showed that the use of 800, 1600, and 3200 IU/kg dosing groups and a single intravenous administration had no significant effect on the general mental state, behavioral activities, central nervous system and digestive system of mice; the use of 350, |
69-79-4 | 10 |